DK1623019T3 - Begrænset glucosetilførsel til dyrecellekultur - Google Patents

Begrænset glucosetilførsel til dyrecellekultur

Info

Publication number
DK1623019T3
DK1623019T3 DK04752591.0T DK04752591T DK1623019T3 DK 1623019 T3 DK1623019 T3 DK 1623019T3 DK 04752591 T DK04752591 T DK 04752591T DK 1623019 T3 DK1623019 T3 DK 1623019T3
Authority
DK
Denmark
Prior art keywords
glucose
cell culture
feeding
restricted
rate
Prior art date
Application number
DK04752591.0T
Other languages
English (en)
Other versions
DK1623019T4 (da
Inventor
Denis Drapeau
Terry Cardoza Stanek
Yen-Tung Luan
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33476770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1623019(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Llc filed Critical Wyeth Llc
Application granted granted Critical
Publication of DK1623019T3 publication Critical patent/DK1623019T3/da
Publication of DK1623019T4 publication Critical patent/DK1623019T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK04752591.0T 2003-05-15 2004-05-17 Begrænset glucosetilførsel til dyrecellekultur DK1623019T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47093703P 2003-05-15 2003-05-15
PCT/US2004/015597 WO2004104186A1 (en) 2003-05-15 2004-05-17 Restricted glucose feed for animal cell culture

Publications (2)

Publication Number Publication Date
DK1623019T3 true DK1623019T3 (da) 2010-09-27
DK1623019T4 DK1623019T4 (da) 2017-03-27

Family

ID=33476770

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04752591.0T DK1623019T4 (da) 2003-05-15 2004-05-17 Begrænset glucosetilførsel til dyrecellekultur

Country Status (10)

Country Link
US (1) US7429491B2 (da)
EP (1) EP1623019B2 (da)
AT (1) ATE472597T2 (da)
DE (1) DE602004027905D1 (da)
DK (1) DK1623019T4 (da)
ES (1) ES2344789T5 (da)
PL (1) PL1623019T5 (da)
PT (1) PT1623019E (da)
SI (1) SI1623019T1 (da)
WO (1) WO2004104186A1 (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
TW201516149A (zh) 2006-09-13 2015-05-01 Abbvie Inc 細胞培養改良
US10982250B2 (en) * 2006-09-18 2021-04-20 Genentech, Inc. Methods of protein production
MX2009004974A (es) * 2006-11-08 2009-05-20 Wyeth Corp Medios diseñado racionalmente para cultivo celular.
WO2009023562A2 (en) * 2007-08-09 2009-02-19 Wyeth Use of perfusion to enhance production of fed-batch cell culture in bioreactors
AU2009236187B2 (en) * 2008-04-17 2012-08-02 Wyeth Llc Methods for enhanced production of bone morphogenetic proteins
EP2331700A2 (en) 2008-08-08 2011-06-15 Biogen Idec MA Inc. Nutrient monitoring and feedback control for increased bioproduct production
CA2932207A1 (en) * 2008-10-20 2010-12-09 Abbvie Inc. Isolation and purification of antibodies using protein a affinity chromatography
CN104974251A (zh) 2008-10-20 2015-10-14 Abbvie公司 在抗体纯化过程中的病毒灭活
US20110117087A1 (en) * 2009-10-26 2011-05-19 Reinhard Franze Method for the production of a glycosylated immunoglobulin
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
RU2592680C2 (ru) 2011-04-29 2016-07-27 Биокон Рисерч Лимитед Способ снижения накопления лактата при культивировании и способ получения антитела
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
HK1211981A1 (en) 2012-09-02 2016-06-03 Abbvie Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
DK2972238T3 (da) 2013-03-15 2023-06-19 Biogen Ma Inc Anvendelse af raman-spektroskopi til monitorering af dyrkningsmedium
JP6563910B2 (ja) 2013-07-04 2019-08-21 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 血清サンプル中の抗薬物抗体を検出するための干渉抑制イムノアッセイ
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
PL3812453T3 (pl) 2013-10-11 2026-07-13 Regeneron Pharmaceuticals, Inc. Hodowla komórkowa zoptymalizowana metabolicznie
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
EP3119876B1 (en) * 2014-03-19 2024-12-18 Pfizer Inc. Method of cell culture
EP3164481A4 (en) 2014-07-02 2018-03-21 Biogen MA Inc. Cross-scale modeling of bioreactor cultures using raman spectroscopy
US20180291329A1 (en) * 2015-05-29 2018-10-11 Biogen Ma Inc. Cell culture methods and systems
US11597903B2 (en) 2015-05-29 2023-03-07 Boehringer Ingelheim International Gmbh Cell-controlled perfusion in continuous culture
TW202440903A (zh) 2015-08-04 2024-10-16 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法（一）
WO2017051347A2 (en) 2015-09-23 2017-03-30 Pfizer Inc. Cells and method of cell culture
AU2018235928B2 (en) 2017-03-14 2023-09-21 Amgen Inc. Control of total afucosylated glycoforms of antibodies produced in cell culture
GB201708655D0 (en) 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
US12325737B2 (en) 2018-03-26 2025-06-10 Amgen Inc. Total afucosylated glycoforms of antibodies produced in cell culture
MY204234A (en) 2018-08-27 2024-08-16 Regeneron Pharma Use of raman spectroscopy in downstream purification
CN113015805B (zh) 2018-11-13 2024-12-03 詹森生物科技公司 抗cd38抗体产生期间的痕量金属的控制
EP3891292A1 (en) 2018-12-06 2021-10-13 Pfizer Inc. Cells with reduced inhibitor production and methods of use thereof
WO2021076855A1 (en) * 2019-10-18 2021-04-22 Janssen Biotech, Inc. Dynamic monosaccharide control processes
US12297451B1 (en) 2019-10-25 2025-05-13 Regeneron Pharmaceuticals, Inc. Cell culture medium
KR20230058094A (ko) 2020-08-31 2023-05-02 리제너론 파아마슈티컬스, 인크. 세포 배양 성능을 개선하고 아스파라긴 서열 변이체를 완화하기 위한 아스파라긴 공급 전략
JP7822149B2 (ja) 2020-10-02 2026-03-02 ファイザー・インク Ｒｓｖ ｆタンパク質生産のための細胞培養工程
MX2023008527A (es) 2021-01-20 2023-07-28 Regeneron Pharma Metodos para mejorar el valor proteico en cultivo celular.
EP4413364A2 (en) 2021-10-07 2024-08-14 Regeneron Pharmaceuticals, Inc. Systems and methods of ph modeling and control
EP4413359A1 (en) 2021-10-07 2024-08-14 Regeneron Pharmaceuticals, Inc. Ph meter calibration and correction
EP4486778A1 (en) 2022-03-02 2025-01-08 Regeneron Pharmaceuticals, Inc. Manufacturing process for high titer antibody
US20240010709A1 (en) 2022-05-25 2024-01-11 Genentech, Inc. Methods for preparing mammalian cells for perfusion cell culture
WO2024218706A1 (en) 2023-04-21 2024-10-24 Pfizer Inc. Improved cells and cell cultures
WO2025088516A1 (en) 2023-10-26 2025-05-01 Pfizer Inc. Method of forming multi-specific antibodies from homodimer antibodies and pharmaceutical product including multi-specific antibodies thus obtained

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631142A (en) 1986-07-01 1997-05-20 Genetics Institute, Inc. Compositions comprising bone morphogenetic protein-2 (BMP-2)
US5013649A (en) 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US5506117A (en) * 1989-10-18 1996-04-09 Cytokinetics, Inc. Biochemical process for growing living cells by measuring the amount of nutrient added to the reaction medium
US5346826A (en) * 1989-10-18 1994-09-13 Andrews Franklin T Process for conducting biochemical reactions
US5318898A (en) 1991-04-02 1994-06-07 Genetics Institute, Inc. Production of recombinant bone-inducing proteins
US5856179A (en) 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
WO1998041611A1 (en) 1997-03-20 1998-09-24 Regents Of The University Of Minnesota Process for the continuous culture of cells
US6531464B1 (en) * 1999-12-07 2003-03-11 Inotek Pharmaceutical Corporation Methods for the treatment of neurodegenerative disorders using substituted phenanthridinone derivatives
US20030087372A1 (en) * 2001-06-13 2003-05-08 Genentech, Inc. Methods of culturing animal cells and polypeptide production in animal cells
DE10255508A1 (de) * 2002-11-27 2004-06-17 Forschungszentrum Jülich GmbH Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen

Also Published As

Publication number Publication date
ES2344789T5 (es) 2017-06-14
ES2344789T3 (es) 2010-09-07
SI1623019T1 (sl) 2010-10-29
EP1623019A1 (en) 2006-02-08
EP1623019B1 (en) 2010-06-30
EP1623019B2 (en) 2017-01-25
DE602004027905D1 (de) 2010-08-12
DK1623019T4 (da) 2017-03-27
WO2004104186A1 (en) 2004-12-02
US7429491B2 (en) 2008-09-30
PL1623019T3 (pl) 2010-10-29
PL1623019T5 (pl) 2018-02-28
PT1623019E (pt) 2010-07-20
ATE472597T2 (de) 2010-07-15
US20050070013A1 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
ATE472597T2 (de) Kontrollierte glukosezufuhr für tierzellkultur
CY1117558T1 (el) Μεθοδος για καλλιεργεια κυτταρων για παραγωγη ουσιων
JP2010110331A5 (da)
WO2008136398A1 (ja) 高濃度アミノ酸含有培地を用いた細胞の培養方法
ATE549395T1 (de) Medium und kultur von embryonalen stammzellen
DE60336548D1 (de) Zelle mit erniedrigter oder deletierter aktivität eines am gdp-fucosetransport beteiligten proteins
ATE412761T1 (de) Methode um rekombinante proteine in cho zellen zu exprimieren
Flamholz et al. Cell biology of photosynthesis over geologic time
TW200500462A (en) Method for producing target substance by fermentation
HRP20070474T3 (en) Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells
CN102268402B (zh) 无血清培养基及cho细胞中高效表达促红素的培养方法
ATE336567T1 (de) Zellkulturmedium
Koebmann et al. The extent to which ATP demand controls the glycolytic flux depends strongly on the organism and conditions for growth
Li et al. High cell density culture of baker's yeast FX‐2 based on pH‐stat coupling with respiratory quotient
DE60123397D1 (de) Methode zur erhöhung der fermentationsgeschwindigkeit von hefe
Jee et al. Influence of redox potential on methanation of methanol by Methanosarcina barkeri in Eh-stat batch cultures
WO2006031840A3 (en) Increasing the stability of recombinant adult human apohemoglobin
Li et al. Enhancement of erythritol production by Trichosporonoides oedocephalis ATCC 16958 through regulating key enzyme activity and the NADPH/NADP ratio with metal ion supplementation
Brewster et al. Whither life? Conjectures on the future evolution of biochemistry
DE50012458D1 (de) Verfahren zur herstellung von hydroxynitril-lyasen
DE59911877D1 (de) Verfahren zur verbesserung des gentransfers von genetischem material in säugerzellen durch die verwendung von p21 (waf-1)
Luo et al. Regeneration of Astragalus adsurgens via somatic embryogenesis from cell suspension protoplasts.
Ross Social Progress: Real Goal Behind GDP Target
UA116537U (uk) Спосіб підвищення антигенпродукуючої біологічної активності перещеплюваних культур клітин flk-71 та flk-sbbl за допомогою наночасток срібла (аргентуму)
Wei et al. Effects of dissolved oxygen and pH on Candida utilis batch fermentation of glutathione